Treatment for brain bleed caused by high blood pressure using Naoxuekang pills
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether an oral traditional Chinese medicine called Naoxuekang dropping pills, given in addition to standard care, can reduce the long-term disability caused by a brain bleed due to high blood pressure. It may help improve recovery for people who have had a recent brain bleed and show signs of small vessel disease on an MRI.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be aged 18 to 80 years.
- You must have had a brain bleed caused by high blood pressure, starting within the last 7 days.
- The bleed must be in the main part of the brain (supratentorial) with a volume of 30 ml or less, or in the lower part (infratentorial) with a volume of 10 ml or less.
- You must be able to have an MRI of the head, and the MRI must show signs of 'small vessel disease' in the brain's small blood vessels.
- You must have a stroke severity score (NIHSS) of 25 or less and a consciousness score (GCS) of 8 or more.
- You must not have surgery planned for the bleed, any active bleeding or ulcer, severe liver or kidney problems, or be pregnant or planning pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving a blood pressure medicine called urapidil, alone or with another medicine called esmolol, can safely lower blood pressure in people who have had a bleeding stroke. It aims to see if this treatment can improve recovery.
This trial tests whether giving a drug called tranexamic acid (helps stop bleeding) along with very careful blood pressure lowering can reduce bleeding growth and improve recovery after a brain bleed. It is for people who arrive at the hospital very quickly (within 2 hours) after symptoms start.
This trial tests a traditional Chinese medicine called Jiedu Huayu to see if it helps people recover from a brain bleed caused by a condition where proteins build up in blood vessel walls (cerebral amyloid angiopathy). The goal is to improve outcomes without surgery.
This study looks at people with a severe type of brain bleed that happens on its own (not from an injury). It compares different treatments to find the best way to help patients recover.
This trial tests if the antibiotic minocycline can help people recover after a spontaneous brain bleed (intracerebral hemorrhage). It is for patients who have a moderate-sized bleed and are within 48 hours of symptoms starting.
This trial tests a traditional Chinese medicine (called Angong Niuhuang Wan) for people who have had a bleeding stroke within the last 6 hours. The goal is to see if this medicine helps reduce the damage from the bleed and improves recovery.
Hear when a new Cerebral Small Vessel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.